Key result
Wearable-Echo-FM outperforms baseline models detecting structural heart disease from 1-lead ECGs using 0.5% training data.
Why the study?
Scaling AI models to detect structural heart diseases from ubiquitous 1-lead wearable ECGs is limited by a lack of diagnostic labels.
Does Wearable-Echo-FM improve the detection of structural heart diseases from 1 lead ECGs compared to a randomly initialized CNN?
Does Wearable-Echo-FM improve the detection of structural heart diseases from 1 lead ECGs compared to a randomly initialized CNN?
Contrastive pre-training of 1 lead ECGs with echocardiographic text reports significantly reduces the amount of labeled data required to develop accurate AI screening models for structural heart disease.
Supports scalable AI screening for structural heart disease via wearable ECGs; extends contrastive pre-training with echocardiographic reports to reduce labeled data requirements.
Background Artificial intelligence (AI) models can now detect patterns of structural heart diseases (SHDs) from electrocardiograms (ECGs), though scaling them requires the broader use of 1 lead ECGs that are now ubiquitous in wearable and portable devices. However, model development for these devices is limited by a lack of diagnostic labels for SHDs for wearable ECGs. Methods Here, we present Wearable-Echo-FM, a foundation model that encodes 1 lead ECGs with information from echocardiographic text reports. Using 194,551 1 lead ECG echo pairs from 77,378 adults (2015-2018), we contrastively pre-trained convolutional neural network (CNN) and RoBERTa encoders. The ECG encoder was fine-tuned on a distinct progressively larger ECG set (250 to 250,260 ECGs) to detect different cardiac disorders (i) left-ventricular systolic dysfunction (LVSD), (ii) diastolic dysfunction, and (iii) a composite SHD. This was compared with a randomly initialized CNN, with both approaches evaluated in an independent held out test set. Results With the full training set, Wearable-Echo-FM matched the baseline CNN (AUROC 0.894 vs 0.884 for LVSD; 0.849 vs 0.843 diastolic dysfunction; 0.887 vs 0.869 composite). With only 0.5% (∼1000 ECGs) of data, it markedly outperformed baseline (0.855 vs 0.548; 0.819 vs 0.582; 0.863 vs 0.496, respectively). Conclusions Contrastive pre-training of 1 lead ECGs on echocardiographic text reduces label requirements for label efficient development of SHD screening models on 1 lead ECGs, providing a foundation for future validation on wearable and portable devices.
No takes yet. Share an insight, caveat, or question.
Knight et al. (2026) studied this question. Wearable-Echo-FM detected structural heart diseases from 1-lead ECGs using only 0.5% of training data, markedly outperforming a baseline model (AUROC 0.819-0.863 vs 0.496-0.582).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: